Paper · 26903404

Regulation of FGF signaling: Recent insights from studying positive and negative modulators.

Korsensky L and 1 other. Semin Cell Dev Biol, 2016. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Regulation of FGF signaling: Recent insights from studying positive and negative modulators. Papers, record 26903404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26903404

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Regulation of FGF signaling: Recent insights from studying positive and negative modulators.; PubMed
Journal: Semin Cell Dev Biol; PubMed
Year: 2016; PubMed
Publication types: Journal Article, Review, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/26903404/; PubMed
DOI: https://doi.org/10.1016/j.semcdb.2016.01.023; PubMed
The journal: https://conductscience.org/library/journal-index/9607332; PubMed
Citations, by iCite: 32; iCite
Relative citation ratio, by iCite: 1.09; iCite
Revised in PubMed: 2018-01-13; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Korsensky L	Lina
2	Ron D	Dina

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Fibroblast Growth Factors	Major topic
Signal Transduction	Major topic
Animals
Embryonic Development
Humans
Models, Animal
Models, Biological
Neoplasms

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMID	Title	Journal	Year	In Papers	Source
41,832,306	FGF family in health and disease.	Mol Biomed	2026	https://conductscience.org/library/papers/41832306	PubMed
40,629,113	Integrating single-cell and spatial transcriptomics reveals the cellular heterogeneity of vestibular schwannoma.	NPJ Precis Oncol	2025	https://conductscience.org/library/papers/40629113	PubMed
39,135,707	Neural regulation of mesenchymal stem cells in craniofacial bone: development, homeostasis and repair.	Front Physiol	2024	https://conductscience.org/library/papers/39135707	PubMed
37,845,690	Fibroblast growth factor signaling in axons: from development to disease.	Cell Commun Signal	2023	https://conductscience.org/library/papers/37845690	PubMed
36,995,433	Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson's disease.	Brain Struct Funct	2023	https://conductscience.org/library/papers/36995433	PubMed
36,966,334	Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.	Mol Cancer	2023	https://conductscience.org/library/papers/36966334	PubMed
36,536,184	Sex difference on fibroblast growth factors (FGFs) expression in skin and wound of streptozotocin(STZ)-induced type 1 diabetic mice.	Mol Biol Rep	2023	https://conductscience.org/library/papers/36536184	PubMed
36,135,368	Feedback Regulation of Signaling Pathways for Precise Pre-Placodal Ectoderm Formation in Vertebrate Embryos.	J Dev Biol	2022	https://conductscience.org/library/papers/36135368	PubMed
35,966,060	Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.	Front Endocrinol (Lausanne)	2022	https://conductscience.org/library/papers/35966060	PubMed
35,193,394	Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.	Open Biol	2022	https://conductscience.org/library/papers/35193394	PubMed

1 to 10 of 27

See all 27 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
ANOS1	3,730	PubTator's text mining	https://conductscience.org/library/genes/3730	NCBI Gene
FLRT3	23,767	PubTator's text mining	https://conductscience.org/library/genes/23767	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26903404

GET https://conductscience.org/api/papers/v1/26903404/cited_by?page=2

API reference For AI assistants